MD
ChemWerth Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Human APIs (Portfolio) | Various (Oncologicals, Antibiotics, Anti-inflammatories, etc.) | Approved |
| Veterinary APIs (Portfolio) | Various Animal Health Indications | Approved |
| Bag APIs | Various | Approved |
| Inhalation APIs | Respiratory Diseases | Approved |
| Injectable APIs | Various (Hospital, Critical Care) | Approved |
| Ophthalmic APIs | Eye Diseases | Approved |
| Oral APIs | Various | Approved |
| Topical APIs | Dermatological Conditions | Approved |
Leadership Team at ChemWerth
PJ
Peter J. Werth
Founder & Chairman
PW
Pete Werth III
President
DM
Dave Moore
Executive Vice President
VA
Vincent Asaro
Chief Financial Officer
VN
Vi Nguyen
Chief Strategic Officer
DX
Dr. Xiping Su
Senior Vice President, Scientific Affairs
MR
Madhu Rao
Strategic Business Partner, ChemWerth India
JY
Jim Yin
General Manager, ChemWerth China & Senior Advisor